Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium

International Journal of Pharmaceutics

Volumn 130, Issue 1, 1996, Pages 141-145

  Arellano, A ^a   Santoyo, S ^a   Martin, C ^a   Ygartua, P ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Diclofenac sodium; Gel formulation; Geraniol; Percutaneous absorption; Skin penetration enhancer; Terpenes

Indexed keywords

CINEOLE; DICLOFENAC; GERANIOL; LIMONENE; MENTHOL; NEROLIDOL; PENETRATION ENHANCING AGENT; TERPENE; THYMOL;

ANIMAL TISSUE; CONTROLLED STUDY; DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT SURVEY; SKIN ABSORPTION; SKIN PENETRATION;

EID: 0029923286     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04364-0     Document Type: Article

References (25)

1. Barry, B.W., Dermatological Formulations: Percutaneous Absorption, Dekker, New York, 1983.
2. Cornwell, P.A. and Barry, B.W., Determination of the mode of action of sesquiterpene skin penetration enhancers. J. Pharm. Pharmacol., 43 (1991a) 56P.
3. Cornwell, P.A. and Barry, B.W., Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-Fluorouracil. J. Pharm. Pharmacol., 46 (1994) 261-269.
4. Cornwell, P.A. and Barry, B.W., The effects of a series of homologous terpene alcohols on the lipid structure of human stratum corneum as assessed by differential scanning calorimetry. In: Scott, R.C., Guy, R.H., Hadgraft, J. and Boddé, H.E. (Eds), Prediction of Percutaneous Penetration: Methods, Measurements, Modelling, IBC Technical Services, London, 1991b, pp. 394-400.
5. Hori, M., Satoh, S., Maibach, H.I. and Guy, R.H., Enhancement of propanolol hydrochloride and diazepam skin absorption: effect of enhancer lipophilicity. J. Pharm. Sci., 80 (1991) 32-35.
6. Iwasa, A., Irimoto, K., Kasai, S., Okuyama, H. and Nagai, T., Effect of nonionic surfactants on percutaneous absorption of diclofenac sodium. Yakuzaigaku, 51 (1991) 16-21.
7. Komata, Y., Inoaka, M., Kaneko, A. and Fujie, T., In vitro percutaneous absorption of thiamine disulfide from a mixture of propylene glycol and fatty acid. J. Pharm. Sci. 81 (1992) 744-746.
8. Morimoto, Y. Sugibayashi, K., Kobayashi, D., Shoji, H., Yamazaki, J. and Kimura, M., A new enhancer/coenhancer system to increase skin permeation of morphine hydrochloride in vitro. Int. J. Pharm., 91 (1993) 9-14.
9. Naito, S. and Tominaga, H., Percutaneous absorption of diclofenac sodium ointment. Int. J. Pharm., 24 (1985) 115-124.
10. Nishihata, T., Kamada, A., Sakai, K., Takahashi, K., Matsumoto, K., Shinozaki, K., Tabata, Y., Keigami, M., Miyagi, T., and Tatsumi, N., Percutaneous absorption of diclofenac in rats and humans: aqueous gel formulation. Int. J. Pharm., 46 (1988) 1-7.
11. Nishihata, T., Kotera, K., Nakano, Y. and Yamazaki, M., Rat percutaneous transport of diclofenac and influence of hydrogenated soya lecithin. Chem. Pharm. Bull., 35 (1987) 3807-3812.
12. Obata, Y., Takayama, K., Machida, Y. and Nagai, T., Combined effect of cyclic monoterpenes and ethanol on percutaneous absorption of diclofenac sodium. Drug Des. Deliv., 8 (1991) 137-144.
13. Obata, Y., Takayama, K., Maitani, Y., Machida, Y. and Nagai, T., Effect of ethanol on skin permeation of nonionized and ionized diclofenac. Int. J. Pharm., 89 (1993) 191-198.
14. Obata, Y., Takayama, K., Okabe, H. and Nagai, T., Effect of cyclic monoterpenes on percutaneous absorption in the case of a water soluble drug (diclofenac sodium). Drug Des. Deliv., 6 (1990) 319-328.
15. Okabe, H. Takayama, K., Ogura, A. and Nagai, T., Effect of limonene and related compounds on the percutaneous absorption of indomethacin. Drug Des. Deliv., 4 (1989) 313-321.
16. Okabe, H., Obata, Y., Takayama, K. and Nagai, T., Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes. Drug Des. Deliv., 6 (1990) 229-238.
17. Priborsky, J., Takayama, K., Obata, Y., Priborska, Z. and Nagai, T., Influence of limonene and laurocapram on percutaneous absorption of nonsteroidal anti-inflammatory drugs. Arzneim.-Forsch. Drug Res., 42 (1992) 116-119.
18. Santoyo, S., Arellano, A., Ygartua, Y. and Martin, C., Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin. Int. J. Pharm., 117 (1995) 219-224.
19. Takahashi, K., Tamagawa, S., Katagi, T., Yoshitomi, H., Kamada, A., Rytting, J., Nishihata, T. and Mizuno, N., In vitro percutaneous transport of sodium diclofenac and diclofenac from oleaginous vehicle. Chem. Pharm. Bull., 39 (1991b) 509-511.
20. Takahashi, K., Tamagawa, S., Katagi, T., Yoshitomi, H., Kamada, A., Rytting, J., Nishihata, T. and Mizuno, N., In vitro transport of sodium diclofenac across rat abdominal skin: Effect of selection of oleaginous component and the addition of alcohols to the vehicle. Chem. Pharm. Bull., 39 (1991a) 154-158.
21. Takayama, K., Kikuchi, K., Obata, Y., Okabe, H., Machida, Y. and Nagai, T., Terpenes as percutaneous absorption promoters. S.T.P. Pharma Sci., 1 (1991) 83-88.
22. Williams, A.C. and Barry, B.W., Differential scanning calorimetry does not predict the activity of terpene penetration enhancers in human skin. J. Pharm. Pharmacol., 42 (1990) 156P.
23. Williams, A.C. and Barry, B.W., Terpenes and the Lipid-Protein-Partitioning theory of skin penetration enhancement. Pharm. Res., 8 (1991a) 17-24.
24. Williams, A.C. and Barry, B.W., Transdermal oestradiol permeation: the effects of terpene penetration enhancers. In: Scott, R.C., Guy, R.H., Hadgraft, J. and Boddé, H.E. (Eds), Prediction of Percutaneous Penetration: Methods, Measurements, Modelling, IBC Technical Services, London, 1991b, pp. 386-393.
25. Yasukawa, T., Akiyoshi, Y., Hattori, A. and Harada, S., Antiinflammatory topical formulations containing indomethacin and diclofenac. Jpn. Kokai Tokkio Koho JP 60146823 A2, Aug. 2nd, 1985.